홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

beta-Bromostyrene → (S)-1,4-Dibenzyl-2-(4-phenyl-but-3-enyl)-piperazine

HRID 1350391
인쇄

반응식

HRID 1350391 반응식
[CH:1]12B[CH:5]([CH2:6][CH2:7][CH2:8]1)[CH2:4][CH2:3][CH2:2]2.[CH2:10]([N:17]1[CH2:22][CH2:21][N:20]([CH2:23][C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)[CH2:19][C@@H:18]1[CH:30]=[CH2:31])[C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.BrC=CC1C=CC=CC=1.[OH-].[Na+]>C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:10]([N:17]1[CH2:22][CH2:21][N:20]([CH2:23][C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)[CH2:19][C@@H:18]1[CH2:30][CH2:31][CH:1]=[CH:8][C:7]1[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1)[C:11]1[CH:12]=[CH:13][CH:14]=[CH:15][CH:16]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 5

HCID 7667beta-BromostyreneHCID 11776TriphenylphosphineHCID 14798Sodium HydroxideHCID 789669-Borabicyclo(3.3.1)nonaneHCID 17759473(S)-1,4-dibenzyl-2-vinylpiperazine

생성물 1

HCID 69487542(S)-1,4-Dibenzyl-2-(4-phenyl-but-3-enyl)-piperazine수율 56%

시약·촉매·용매 1

HCID 178418397HCID 178418397, 화합물촉매

실험 절차

Combine 9-borabicyclo[3.3.1]nonane (81.6 mL, 40.3 mmol, 0.5 M in THF) and (S)-1,4-dibenzyl-2-vinyl-piperazine (2.0 g, 6.8 mmol)and stir at ambient temperature. After 16 hours, take half volume of it, add triphenylphosphine (143 mg, 0.55 mmol), tetrakis(triphenylphosphine)palladium(0) (78.5 mg, 0.068 mmol), and beta-bromostyrene (0.93 g, 5.08 mmol). Add 3N NaOH (2.8 mL, 8.8 mmol) slowly, gas evolution will occur. Heat to reflux. After 24 hours, cool to ambient temperature. Remove the solvent under reduced pressure, dilute with diethyl ether, wash with 1N HCl, 1N NaOH, H2O and brine, dry the organic layer over Na2SO4, filter and concentrate under reduced pressure. Purification by flash chromatography on silica gel using 2N ammonia in methanol-methylene chloride (0.5%–3%) as the eluent, collect compound and pass through 10 g SCX column, using MeOH, 0.2 N NH3 in MeOH as eluent to give the title compound (750 mg, 56%): mass spectrum (electrospray): m/z=397.3 (M+1); 1H NMR (300 MHz, CDCl3): δ7.35–7.16 (m, 15H), 6.36–6.12 (m, 2H), 4.01 (d, 1H, J=13.2), 3.56–3.43 (m, 2H), 3.25 (d, 1H, J=13.4 Hz), 2.75–2.68 (m, 2H), 2.56–2.48 (m, 2H), 2.29–2.13 (m, 5H), 1.82–1.76 (m, 2H).

후처리

  1. temperatureHeat to reflux
  2. waitAfter 24 hours
  3. customRemove the solvent under reduced pressure
  4. additiondilute with diethyl ether
  5. washwash with 1N HCl, 1N NaOH, H2O and brine
  6. dry with materialdry the organic layer over Na2SO4
  7. filtrationfilter
  8. concentrationconcentrate under reduced pressure
  9. customPurification by flash chromatography on silica gel using 2N ammonia in methanol-methylene chloride (0.5%–3%) as the eluent
  10. customcollect compound

출처 및 근거

ORD 기록
ord-915ff01d467d4dcd90feda8425405fd4
출처 데이터셋
uspto-grants-2007_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07214673B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트